Please use this identifier to cite or link to this item:
Title: Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis.
Issue Date: May-2019
Citation: Haematologica.2019 May;(104)5:e211-e214
PMID: 30442728
Rights: openAccess
Appears in Collections:Hospitales > H. U. Infanta Leonor > Artículos

Files in This Item:
File Description SizeFormat 
PMC6518912.pdf539.65 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.